Compare Agilent Technologies Inc (A) vs Datadog Inc (DDOG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Datadog Inc — how do they compare? Agilent Technologies Inc trades at $128.87 (market cap $37.04B), while Datadog Inc trades at $256.71 (market cap $91.41B). The key difference: Datadog Inc is far larger — about 2.5× Agilent Technologies Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Datadog Inc pays none. Which is the better fit depends on your goals.
| A | DDOG | |
|---|---|---|
Market Cap | $37.04B | $91.41B |
Sector | Health | Technology |
52-Week High | $157.20 | $277.49 |
52-Week Low | $110.24 | $102.62 |
Enterprise Value | $38.59B | $87.94B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Datadog (DDOG) trades at $256.81, down 1.36% over the past day but maintains a bullish technical outlook with strong moving average signals. The company reported revenue of $3.43B in 2025 with consistent earnings beats, though net income margin compressed to 3.69%. Recent acquisition of Adaptive ML aims to bolster AI research capabilities, while analyst sentiment remains overwhelmingly positive with 83% buy ratings.
DDOG presents growth potential through cloud infrastructure demand and AI integration, but faces risks from high valuation multiples (P/E 654.79) and negative cash flow trends. Competition in observability software and execution challenges could pressure margins, though institutional support provides stability. The stock's trajectory hinges on sustaining revenue growth while improving profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Datadog Inc
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered as software-as-a-service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of different applications throughout their businesses.
Read more on DDOG →
